Global Varicella Vaccine Market to Reach US$ 3.07 Billion by 2034, Expanding at a CAGR of 5.79% (2026–2034)
The Varicella Vaccine Market is expanding as public health authorities, healthcare providers, and pharmaceutical manufacturers accelerate pediatric immunization programs, expand adult catch-up coverage, and strengthen vaccine supply chains. Growth is supported by national immunization program (NIP) inclusions, increasing awareness of varicella-zoster virus (VZV) complications, routine two-dose...
0 Commentaires 0 Parts 12 Vue